These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32739892)

  • 21. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
    Dejaco C; Singh YP; Perel P; Hutchings A; Camellino D; Mackie S; Matteson EL; Dasgupta B
    Ann Rheum Dis; 2015 Oct; 74(10):1808-17. PubMed ID: 26359489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
    Dasgupta B; Cimmino MA; Maradit-Kremers H; Schmidt WA; Schirmer M; Salvarani C; Bachta A; Dejaco C; Duftner C; Jensen HS; Duhaut P; Poór G; Kaposi NP; Mandl P; Balint PV; Schmidt Z; Iagnocco A; Nannini C; Cantini F; Macchioni P; Pipitone N; Amo MD; Espígol-Frigolé G; Cid MC; Martínez-Taboada VM; Nordborg E; Direskeneli H; Aydin SZ; Ahmed K; Hazleman B; Silverman B; Pease C; Wakefield RJ; Luqmani R; Abril A; Michet CJ; Marcus R; Gonter NJ; Maz M; Carter RE; Crowson CS; Matteson EL
    Ann Rheum Dis; 2012 Apr; 71(4):484-92. PubMed ID: 22388996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of polymyalgia rheumatica in a cohort of patients with idiopathic inflammatory myopathy.
    Douglass-Molloy H; Limaye V
    Clin Rheumatol; 2020 Apr; 39(4):1217-1221. PubMed ID: 31919772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyalgia rheumatica with normal erythrocyte sedimentation rate: clinical aspects.
    Martínez-Taboada VM; Blanco R; Rodríguez-Valverde V
    Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S34-7. PubMed ID: 10948758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of methotrexate in polymyalgia rheumatica in routine rheumatology clinical care.
    Ruediger C; Nguyen L; Black R; Proudman S; Hill C
    Intern Med J; 2020 Sep; 50(9):1067-1072. PubMed ID: 32043726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.
    Leeb BF; Rintelen B; Sautner J; Fassl C; Bird HA
    Arthritis Rheum; 2007 Jun; 57(5):810-5. PubMed ID: 17530664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios.
    Binard A; De Bandt M; Berthelot JM; Saraux A;
    Arthritis Rheum; 2007 Apr; 57(3):481-6. PubMed ID: 17394219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
    Gonzalez-Gay MA; Garcia-Porrua C; Salvarani C; Olivieri I; Hunder GG
    J Rheumatol; 2000 Sep; 27(9):2179-84. PubMed ID: 10990231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome.
    González-Gay MA; Rodríguez-Valverde V; Blanco R; Fernández-Sueiro JL; Armona J; Figueroa M; Martínez-Taboada VM
    Arch Intern Med; 1997 Feb; 157(3):317-20. PubMed ID: 9040299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments.
    Naye F; Toupin-April K; de Wit M; LeBlanc A; Dubois O; Boonen A; Barton JL; Fraenkel L; Li LC; Stacey D; March L; Barber CEH; Hazlewood GS; Guillemin F; Bartlett SJ; Berthelsen DB; Mather K; Arnaud L; Akpabio A; Adebajo A; Schultz G; Sloan VS; Gill TK; Sharma S; Scholte-Voshaar M; Caso F; Nikiphorou E; Nasef SI; Campbell W; Meara A; Christensen R; Suarez-Almazor ME; Jull JE; Alten R; Morgan EM; El-Miedany Y; Singh JA; Burt J; Jayatilleke A; Hmamouchi I; Blanco FJ; Fernandez AP; Mackie S; Jones A; Strand V; Monti S; Stones SR; Lee RR; Nielsen SM; Evans V; Srinivasalu H; Gérard T; Demers JL; Bouchard R; Stefan T; Dugas M; Bergeron F; Beaton D; Maxwell LJ; Tugwell P; Décary S
    Semin Arthritis Rheum; 2024 Apr; 65():152344. PubMed ID: 38232625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic difficulties in polymyalgia rheumatica cases with normal erythrocyte sedimentation rate and C-reactive protein values.
    Kara M; Alp G; Koç AM
    Medicine (Baltimore); 2023 Sep; 102(39):e35385. PubMed ID: 37773830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of the polymyalgia rheumatica activity score in primary care practice.
    Binard A; Lefebvre B; De Bandt M; Berthelot JM; Saraux A;
    Ann Rheum Dis; 2009 Apr; 68(4):541-5. PubMed ID: 18477738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries.
    Manzo C; Milchert M; Venditti C; Castagna A; Nune A; Natale M; Brzosko M
    Life (Basel); 2022 Jun; 12(7):. PubMed ID: 35888074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.
    Hutchings A; Hollywood J; Lamping DL; Pease CT; Chakravarty K; Silverman B; Choy EH; Scott DG; Hazleman BL; Bourke B; Gendi N; Dasgupta B
    Arthritis Rheum; 2007 Jun; 57(5):803-9. PubMed ID: 17530680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the health assessment questionnaire to evaluate functional status in polymyalgia rheumatica.
    Kalke S; Mukerjee D; Dasgupta B
    Rheumatology (Oxford); 2000 Aug; 39(8):883-5. PubMed ID: 10952744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
    Dasgupta B; Cimmino MA; Kremers HM; Schmidt WA; Schirmer M; Salvarani C; Bachta A; Dejaco C; Duftner C; Jensen HS; Duhaut P; Poór G; Kaposi NP; Mandl P; Balint PV; Schmidt Z; Iagnocco A; Nannini C; Cantini F; Macchioni P; Pipitone N; Del Amo M; Espígol-Frigolé G; Cid MC; Martínez-Taboada VM; Nordborg E; Direskeneli H; Aydin SZ; Ahmed K; Hazleman B; Silverman B; Pease C; Wakefield RJ; Luqmani R; Abril A; Michet CJ; Marcus R; Gonter NJ; Maz M; Carter RE; Crowson CS; Matteson EL
    Arthritis Rheum; 2012 Apr; 64(4):943-54. PubMed ID: 22389040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A disease activity score for polymyalgia rheumatica.
    Leeb BF; Bird HA
    Ann Rheum Dis; 2004 Oct; 63(10):1279-83. PubMed ID: 15361387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of 2012 EULAR/ACR criteria for polymyalgia rheumatica to Korean patients previously classified by Chuang and Hunder criteria or Healey criteria.
    Park ES; Ahn SS; Jung SM; Song J; Park YB; Lee SW
    Int J Rheum Dis; 2018 Oct; 21(10):1838-1843. PubMed ID: 30168262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey.
    Dasgupta B; Salvarani C; Schirmer M; Crowson CS; Maradit-Kremers H; Hutchings A; Matteson EL;
    J Rheumatol; 2008 Feb; 35(2):270-7. PubMed ID: 18050370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of the polymyalgia rheumatica activity score for diagnosing disease flares.
    Binard A; de Bandt M; Berthelot JM; Saraux A;
    Arthritis Rheum; 2008 Feb; 59(2):263-9. PubMed ID: 18240260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.